Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivit...
Lead publication strategy and execution for oncology assets at an early-stage biotech, ensuring high-impact dissemination of clinical data across internal and external stakeholders.